Cardiovascular Systems, Inc. to Unveil New Data from Confirm Study Series at NCVH Conference  
6/4/2013 10:59:31 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), will share new data from its CONFIRM study series at the 2013 New Cardiovascular Horizons (NCVH) conference in New Orleans.

The CONFIRM series of patients evaluated the use of CSI’s orbital atherectomy system as a treatment for peripheral arterial disease (PAD) —in above- and below-the-knee lesions— in a real world population of patients (with no exclusions).

Help employers find you! Check out all the jobs and post your resume.